EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Anti-Inflammatory Potential of Pomegranate Extract (Pomanox®) in a Reconstituted Human Corneal Epithelium Model

Marcos Peñalver-Mellado, Fredy Silva-Fuentes, Agustín Villar, Anna Mula, Andrea Zangara

Journal of Clinical & Translational Ophthalmology · 2023

DOI: 10.3390/jcto1020007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical & Translational Ophthalmology, 2023. Verfasst von Marcos Peñalver-Mellado und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An in vitro study was conducted using a model of reconstituted human corneal epithelial (SkinEthic™ HCE/Human Corneal Epithelium) to test the modulation of cytokines secretion activity of Pomanox® (PMX), a standardized commercial extract of pomegranate fruit characterized by high punicalagin α + β content. Cell viability and inhibition of the release of interleukin-8 (IL-8) was evaluated in four conditions: negative control, positive inflammatory control with lipopolysaccharide (LPS) from Escherichia coli, positive anti-inflammatory control (LPS plus dexamethasone), and LPS plus PMX after 24 h of culture. The mean (±standard error of mean (SEM)) IL-8 level was 48.7 ± 5.1 pg/mL in the PMX condition vs. 172.7 ± 19.3 and 26.6 ± 1.2 in the LPS from E. coli and negative control, respectively (p < 0.05) and 93.8 ± 8.7 pg/mL in LPS plus dexamethasone (p = 0.165). The percentages of inhibition of IL-8 release were 45.7% for LPS plus dexamethasone and 63.8% for LPS plus PMX. The percentage of cell viability (86%) was also higher for the LPS plus PMX condition. The present findings add evidence to the anti-inflammatory effect of a PMX in an in vitro model of reconstituted corneal epithelial cells.

Zitieren

APA

Peñalver-Mellado, M., Silva-Fuentes, F., Villar, A., Mula, A., & Zangara, A. (2023). In Vitro Anti-Inflammatory Potential of Pomegranate Extract (Pomanox®) in a Reconstituted Human Corneal Epithelium Model. Journal of Clinical & Translational Ophthalmology. https://doi.org/10.3390/jcto1020007

Vancouver

Peñalver-Mellado M, Silva-Fuentes F, Villar A, Mula A, Zangara A. In Vitro Anti-Inflammatory Potential of Pomegranate Extract (Pomanox®) in a Reconstituted Human Corneal Epithelium Model. Journal of Clinical & Translational Ophthalmology. 2023. doi:10.3390/jcto1020007

BibTeX
@article{PealverMellado2023,
  author = {Peñalver-Mellado, Marcos and Silva-Fuentes, Fredy and Villar, Agustín and Mula, Anna and Zangara, Andrea},
  title = {In Vitro Anti-Inflammatory Potential of Pomegranate Extract (Pomanox®) in a Reconstituted Human Corneal Epithelium Model},
  journal = {Journal of Clinical & Translational Ophthalmology},
  year = {2023},
  doi = {10.3390/jcto1020007}
}
Kostenlos starten →